Investors

Welcome from the CEO

At TruSpine, our mission is to build a leading independent medical devices company that is at the forefront of reshaping the way clinicians approach spinal (vertebral) stabilisation and therefore alter and significantly improve how severe back pain is treated. The market for spinal stabilisation is estimated at $10.1 billion globally and we are well positioned to disrupt this with our suite of products. 

The Company is developing uniquely disruptive technologies to revolutionise the spinal stabilisation market, commencing with three flagship pioneering, spinal devices:

 

• The Cervi-LOK™
• GRASP Laminoplasty
• Faci-LOK™

These unique devices represent a quantum shift in spinal fixation, fusion & laminoplasty techniques, provide exceptional  stabilisation and uniquely, do not alter the bone anatomy by requiring screws, staples, or other such attachments which dominate the current technologies.  As a Company, our philosophy and mantra is one of preserving nature’s design, and as such, the devices have been designed to be safer, faster and easier to implant. The cost savings to patients, insurers and surgeons are significant. The technology is minimally intrusive, minimally invasive and fully reversable.

We welcome engagement with our shareholders and prospective investors. Please contact us at [email protected]